Trial Profile
Effect of Nebivolol on Blood Pressure in a Model of Hypertension Sensitive to Potentiation of Nitric Oxide Bioactivity.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary) ; Metoprolol tartrate; Sildenafil
- Indications Hypertension
- Focus Therapeutic Use
- 30 Apr 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 10 Nov 2014 Planned primary completion date changed from 1 Dec 2013 to 1 Jul 2014 according to ClinicalTrials. gov.
- 24 Sep 2014 Planned End Date changed from 1 Dec 2013 to 1 Feb 2015 according to ClinicalTrials. gov.